Shalby Limited — Investor Meet, 30-10-2024: Analysts/Institutional Investor Meet/Con. Call Updates

Shalby Limited reported its Q2 FY25 financial performance, with consolidated revenue reaching ₹2,747 million, marking a 12.9% year-on-year increase, although EBITDA declined by 31.5%. Standalone revenue was ₹2,176 million, down 2.4%. The company's diverse business segments, including hospital operations and homecare, showed growth, with notable advancements in surgical procedures and a focus on franchise development. Shalby aims for substantial expansion in orthopedic services and implant manufacturing, reinforcing its market leadership.